Stifel Remains Buyers Of Ophthotech As Year-End Binary Event Looms By: Benzinga via Benzinga December 02, 2016 at 09:13 AM EST Top-line data is expected from two of Ophthotech Corp (NASDAQ: OPHT)'s pivotal Phase III trials in the next month. Leading into the ... Read More >> Related Stocks: Ophthotech Corp Regeneron Pharmaceuticals